Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 27, 2012

View Archived Issues

TMX-202 shows potential as intravesically administered bladder cancer therapy

Orteronel investigated in nonmetastatic prostate cancer

Updated results presented from the AXIS trial

New VCP inhibitors designed in Japan

Novel metabotropic glutamate mGlu2 receptor antagonists patented

Prous Institute for Biomedical Research reports new multitargeted products

Eli Lilly presents novel products with potential to treat cancer

New 11-beta-HSD1 inhibitors developed at High Point Pharmaceuticals

Auriga identifies novel potential therapeutics for photodermatosis

Selective serotonin transporter radioligand investigated in healthy subjects and patients

Sirona Biochem assesses lead product in model of diabetes

Novartis seeks Afinitor line extensions in Japan

EMA accepts Takeda's MAA for peginesatide

Angiochem and GSK launch new collaboration

Eisai offers overview of third quarter of fiscal 2011

Neuronex enters merger agreement

CSL Behring screens first patient in global rVIII-SingleChain study

European Commission approves Glivec label update

Chinese institute divulges new beta-secretase 1 inhibitors

Esmya approved in Europe

Scripps Research Institute receives funds to develop new HIV inhibitors

Sanofi discloses new platelet adhesion-inhibiting peptides

Galen acquires chemotherapy agent from Gilead

FDA approves protocol amendment to ARISER study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Neutrophils put the brakes on fat loss
BioWorld Science
Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...
Peptidream reveals milestone in Alnylam collaboration
BioWorld Science
Peptidream Inc. has announced a preclinical development milestone in its collaboration with Alnylam Pharmaceuticals Inc. under their siRNA conjugate discovery...